BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28482404)

  • 1. [Research advances in nonalcoholic fatty liver disease and alcoholic liver disease in 2016].
    Chen YS; Wang BY; Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):181-186. PubMed ID: 28482404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
    Leung TM; Nieto N
    J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.
    Lau JK; Zhang X; Yu J
    J Pathol; 2017 Jan; 241(1):36-44. PubMed ID: 27757953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
    Carr RM; Oranu A; Khungar V
    Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH; Terrault NA; Harrison SA
    Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current epidemiology and pathogenesis of non-alcoholic fatty liver disease-associated liver cancer].
    Chen DF; Sun WJ; Liu KJ; Wen LZ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):111-114. PubMed ID: 28297796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advances in the pathogenesis of non-alcoholic fatty liver disease-associated liver cancer].
    Huang W; Zhang XX
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):157-160. PubMed ID: 28297806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of probiotics in treatment of nonalcoholic fatty liver disease].
    Chen M; Wang MC; Ni R; Wang J; Wang L; Wang GN; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):77-80. PubMed ID: 28297790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.
    Brea Á; Pintó X; Ascaso JF; Blasco M; Díaz Á; González-Santos P; Hernández Mijares A; Mantilla T; Millán J; Pedro-Botet J;
    Clin Investig Arterioscler; 2017; 29(3):141-148. PubMed ID: 27692633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Epidemiology of Nonalcoholic Fatty Liver Disease.
    Murag S; Ahmed A; Kim D
    Gut Liver; 2021 Mar; 15(2):206-216. PubMed ID: 32921636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autophagy in chronic liver diseases: a friend rather than a foe?].
    Gual P; Gilgenkrantz H; Lotersztajn S
    Med Sci (Paris); 2017 Mar; 33(3):252-259. PubMed ID: 28367811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of CD36 in nonalcoholic fatty liver disease].
    Zhan Z; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):953-956. PubMed ID: 29325301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
    Schild MH; Guy CD
    Surg Pathol Clin; 2018 Jun; 11(2):267-285. PubMed ID: 29751874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research advances in diagnosis of non-alcoholic fatty liver disease].
    Wang JH; Yu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):115-118. PubMed ID: 28297797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.